The company
Neuraxis, Inc.
NRXS · NYSE American
NRXS stood above a rising 150-day average in 41 of the last 52 weekly readings, including each of the last 1 week. It is 11.8% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 1 in a row
- Industry in uptrend
- 27% -7 in 4 wk
- Insider buys, 12 months
- $1.8M
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 30 (+6)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 41 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Timothy Robert HenrichsChief Financial Officer | bought | 1,937at $4.84 | 8 Oct 2026filed 8 Oct 2026 |
| Thomas Joeseph CarricoCRO, CCO, CPO | bought | 328at $4.84 | 8 Oct 2026filed 8 Oct 2026 |
| Brian Allen CarricoChief Executive Officer | bought | 268at $4.84 | 8 Oct 2026filed 8 Oct 2026 |
| Brian Allen CarricoChief Executive Officer | bought | 8,060at $1.96 | 1 Apr 2026filed 3 Apr 2026 |
| Thomas Joeseph CarricoCRO, CCO, CPO | bought | 667at $1.96 | 1 Apr 2026filed 3 Apr 2026 |
| Timothy Robert HenrichsChief Financial Officer | bought | 7,593at $1.96 | 1 Apr 2026filed 3 Apr 2026 |
| Brian Hannasch10% owner | bought | 40,000at $4.92 | 12 Feb 2026filed 13 Feb 2026 |
| Brian Hannasch10% owner | bought | 40,000at $4.65 | 11 Feb 2026filed 13 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| AIGH Capital Management LLCadded · filed 7 Aug 2026 | 519,938$3.8M | +119,938+30.0% |
| Rosalind Advisors, Inc.added · filed 14 Aug 2026 | 508,055$3.0M | +221,917+77.6% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 335,793$2.5M | +109,926+48.7% |
| MONEY CONCEPTS CAPITAL CORPadded · filed 4 Aug 2026 | 228,029$1.7M | +2,474+1.1% |
| RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026 | 169,400$1.2M | +92,446+120.1% |
| MARSHALL WACE, LLPadded · filed 13 Aug 2026 | 128,755$941K | +50,060+63.6% |
| PARSONS CAPITAL MANAGEMENT INCadded · filed 24 Jul 2026 | 117,808$861K | +1,082+0.9% |
| Panoramic Capital, LLCreduced · filed 14 Aug 2026 | 115,000$841K | -75,000−39.5% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 96,361$705K | +3,256+3.5% |
| CITADEL ADVISORS LLCnew · filed 14 Aug 2026 | 85,053$622K | +85,053 |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.